Hyungseok Kang

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Tracy Dalton, Peter Cegielski, Somsak Akksilp et al. · The Lancet · 2012 · 224 citations · Full text

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Preventive Medicine +12

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis

Seung-Kyu Park, Jinhee Kim, Hyungseok Kang et al. · International Journal of Infectious Diseases · 2008 · 38 citations · Full text

Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea

Hyungseok Kang, Kyung‐Wook Jo, Doosoo Jeon et al. · Respiratory Medicine · 2020 · 35 citations

Pulmonary Tuberculosis, Antibiotics, South Korea +9

Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea: Experience from Gyeongsangnam-do

Byung-Han Ryu, Sun In Hong, Su Jin Lim et al. · Journal of Korean Medical Science · 2021 · 29 citations · Full text

Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid

Hyeontaek Hwang, Hyungseok Kang, Yong-Soo Kwon et al. · Clinical Infectious Diseases · 2021 · 28 citations